-
1 Comment
From a valuation standpoint, the stock is 99.2% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 9.9.
Based on the above factors, Oxford Immunotec Global PLC gets an overall score of 1/5.
| ISIN | None |
|---|---|
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| CurrencyCode | EUR |
| Exchange | F |
| Beta | 1.38 |
|---|---|
| Target Price | None |
| PE Ratio | None |
| Market Cap | 473M |
| Dividend Yield | None |
As of March 8, 2021, operates as a subsidiary of PerkinElmer (UK) Holdings Limited.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for OX1.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024
